BioGaia AB (UK) Today
| 0GTN Stock | 115.60 1.30 1.11% |
PerformanceInsignificant
| Odds Of DistressLow
|
BioGaia AB is selling for under 115.60 as of the 20th of March 2025; that is 1.11 percent decrease since the beginning of the trading day. The stock's lowest day price was 115.4. BioGaia AB has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Business Domain Commercial & Professional Services | Classification Industrials |
BioGaia AB is entity of United Kingdom. It is traded as Stock on LSE exchange. More on BioGaia AB ser
Moving against BioGaia Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
BioGaia Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BioGaia AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BioGaia AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
BioGaia AB ser (0GTN) is traded on London Exchange in UK and employs 225 people. BioGaia AB is listed under Environmental & Facilities Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.77 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioGaia AB's market, we take the total number of its shares issued and multiply it by BioGaia AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioGaia AB ser operates under Commercial Services & Supplies sector and is part of Industrials industry.
BioGaia AB generates positive cash flow from operations, but has no cash available
Check BioGaia AB Probability Of Bankruptcy
Ownership AllocationThe market capitalization of BioGaia AB ser is USD9.77 Billion. Over half of BioGaia AB's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in BioGaia AB. Please watch out for any change in the institutional holdings of BioGaia AB ser as this could mean something significant has changed or is about to change at the company. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check BioGaia Ownership Details
BioGaia AB ser Risk Profiles
Although BioGaia AB's alpha and beta are two of the key measurements used to evaluate BioGaia AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.25 | |||
| Semi Deviation | 1.38 | |||
| Standard Deviation | 1.71 | |||
| Variance | 2.92 |
BioGaia Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioGaia AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
BioGaia AB Corporate Management
Elected by the shareholders, the BioGaia AB's board of directors comprises two types of representatives: BioGaia AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioGaia. The board's role is to monitor BioGaia AB's management team and ensure that shareholders' interests are well served. BioGaia AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioGaia AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Eva Nelson | Co Mang | Profile | |
| Ludvig Milesson | Chief Officer | Profile | |
| Jens Velling | Chief Officer | Profile | |
| Gianfranco Grompone | Chief Development | Profile | |
| Jonathan Gromark | Sustainability Manager | Profile |
Additional Tools for BioGaia Stock Analysis
When running BioGaia AB's price analysis, check to measure BioGaia AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioGaia AB is operating at the current time. Most of BioGaia AB's value examination focuses on studying past and present price action to predict the probability of BioGaia AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioGaia AB's price. Additionally, you may evaluate how the addition of BioGaia AB to your portfolios can decrease your overall portfolio volatility.